MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijid.2026.108903

Медицинская библиотека · International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026

Association of acute-phase corticosteroid use with SARS-CoV-2 reinfection among hospitalized COVID-19 survivors: a 3-year follow-up study.

Zhang Hui, Xiang Chunyan, Mu Yuxian, Gu Xiaoying, Zhang Rongling, Liu Dong, Chu Ziyi, Wang Yeming, Cao Bin

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Although corticosteroids are a standard treatment for severe COVID-19, their potential impact on the long-term risk of SARS-CoV-2 reinfection remains unclear. This study assessed whether corticosteroid use during acute infection increases 3-year reinfection risk.

METHODS

This study included adult COVID-19 survivors who were discharged from Jin Yin-tan Hospital (Wuhan, China) between January and May 2020 and completed the 3-year follow-up. Analyses were grouped by corticosteroid use (use vs non-use) and further by treatment duration (<7, 7-10, >10 days), cumulative dose (≤560 mg vs >560 mg methylprednisolone equivalents), and initiation timing. The primary outcome was reinfection risk; severity of reinfection and other clinical outcomes were designated as secondary outcomes.

RESULTS

Among 913 participants (median age 61.0 years, 53.8% male), 677 (74.1%) received supplemental oxygen during hospitalization. The reinfection proportion (70.4% [157 of 223] vs 70.0% [483 of 690], P = 0.976) was comparable between the corticosteroid and non-corticosteroid group. Reinfection severity, evaluated by the pneumonia incidence and oxygen requirement, did not differ significantly. Further analyses revealed neither treatment duration, cumulative dose, nor initiation timing was significantly associated with reinfection risk or severity. These findings remained consistent across vaccinated and unvaccinated subgroups.

CONCLUSIONS

Our findings provided evidence that corticosteroids during acute COVID-19 was not associated with an increased susceptibility to SARS-CoV-2 reinfection.

Для цитирования: Zhang Hui, Xiang Chunyan, Mu Yuxian, Gu Xiaoying, Zhang Rongling, Liu Dong, Chu Ziyi, Wang Yeming, Cao Bin. Association of acute-phase corticosteroid use with SARS-CoV-2 reinfection among hospitalized COVID-19 survivors: a 3-year follow-up study.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2026. DOI: 10.1016/j.ijid.2026.108903.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.